Late-Onset Cytomegalovirus Disease in Liver Transplant Recipients Despite Antiviral Prophylaxis1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late-Onset Cytomegalovirus Disease in Liver Transplant Recipients Despite Antiviral Prophylaxis1

Published:2004-11-15 Issue:9 Volume:78 Page:1390-1396
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Limaye Ajit P.,Bakthavatsalam Ramaswamy,Kim Hyung W.,Kuhr Christian S.,Halldorson Jeffrey B.,Healey Patrick J.,Boeckh Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference31 articles.

1. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group.;Gane;Lancet,1997

2. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.;Lowance;N Engl J Med,1999

3. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.;Snydman;N Engl J Med,1987

4. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.;Valantine;Circulation,1999

5. Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation.;Wagner;Transplantation,1995

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation Pathology;MacSween's Pathology of the Liver;2024

2. Extended duration letermovir in allogeneic hematopoietic stem cell transplant;Transplant Immunology;2023-12

3. Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology);JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-10

4. Real world effectiveness and feasibility of pharmacist‐led preemptive CMV treatment in high risk (CMV D+R−) liver transplant;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-07-16

5. Preemptive therapy versus universal prophylaxis: Time for reconciliation?;Transplant Infectious Disease;2023-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3